Advanced Code injection

Ontario Industry Updates

Therapure Biomanufacturing Announces FDA Approval for Manufacturing of Insmed’s ARIKAYCE®

Therapure Biomanufacturing announced approval for the manufacturing of partner Insmed’s ARIKAYCE® at its Mississauga facility by the U.S. FDA. ARIKAYCE is the first and only treatment approved by the FDA specifically for patients with Mycobacterium avium complex lung disease, a chronic and debilitating condition that can significantly increase patient morbidity and mortality.

Canada's Economic Strategy Tables Release Health and Biosciences Report

The report entitled “The Innovation and Competitiveness Imperative: Seizing Opportunities for Growth”, contains recommendations from six sectors with high growth potential, including the health and biosciences sector. The report outlined the roadmap to doubling the size of the health and biosciences sector and becoming a top-three global hub.

CABHI announces new Mentorship, Capital and Continuation Program

The Centre for Aging + Brain Health Innovation (CABHI), led by Baycrest and in partnership with National Bank, announced the launch of a new Mentorship, Capital and Continuation Program (MC2). MC2 will accelerate market-ready healthcare innovations for the aging population from bench to bedside more quickly and efficiently.